Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

02/19 05:05   Russia political and economic calendar: February 19
 
02/19 05:00   INTERFAX RUSSIA AND CIS BUSINESS AND FINANCIAL NEWS
 
02/18 22:07   New anti-Russian sanctions indicate EU's pro-U.S. policy - Duma's Slutsky (Part 2)
 
02/18 21:50   5 Ukrainian saboteurs hit landmine trying to infiltrate republic, Luhansk says
 
02/18 21:48   New anti-Russian sanctions indicate EU's pro-U.S. policy - Duma's Slutsky
 
02/18 21:43   Authorities considering adjustments to local history textbook criticized by Crimean Tatars
 
02/18 21:31   Michael Calvey, Philippe Delpal being held in good conditions - Public Monitoring Commission member Yenikeyev
 
02/18 21:28   Radicals protesting near Ukrainian Interior Ministry light firecrackers
 
02/18 21:23   EU'S SUPPORT FOR ANTI-RUSSIAN SANCTIONS FORCED BY U.S. INDICATES BRUSSELS' PRO-U.S. POLICY - DUMA'S SLUTSKY
 
02/18 21:21   Baring Vostok founder Calvey hopes for business ombudsman's aid for his release from custody - Public Monitoring Commission member
 




 

Interfax.com  |  Interfax news  |  Pharmstandard in talks to buy drug maker AVVA Rus...


News headlines


December 11, 2012 10:48

Pharmstandard in talks to buy drug maker AVVA Rus - paper

MOSCOW. Dec 11 (Interfax) - Pharmstandard, one of Russia's leading pharmaceutical companies, is in talks to buy drug maker AVVA Rus, which owns a factory in Kirov, Kommersant reported on Tuesday, citing a partner of the drug maker.

"Pharmstandard expects to close the deal to acquire AVVA Rus very soon," he said.

Drug distributor Protek, which is in litigation with AVVA Rus over product deliveries, is also aware of the upcoming deal. "We have been approached by Pharmstandard's lawyers, who said that soon they will be handling AVVA's affairs," a source at Protek said.

Pharmstandard's head of corporate communications, Ilya Krylov said negotiations are being held with AVVA "on the subject of cooperation in the area of marketing and sales of a number of drugs." There talks are not about acquiring the company, he said.

A manager at AVVA Rus confirmed the existence of "certain negotiations of company management with Pharmstandard," but declined to provide details.

AVVA Rus owns the Sti-Med-Sorb factory in Kirov. The company is wholly owned by Switzerland's AVVA Pharmaceuticals AG. AVVA Rus closed 2011 with net profit of 287.9 million rubles on revenue of 1.9 billion rubles.

The company's main product is Lactofiltrum, which is used to treat dysbacteriosis and accounts for about 50% of AVVA Rus' sales. Its two other leading products are Filtrum (used to treat food poisoning, enteric infections, alcohol intoxication) and Mikrazim (a digestive enzyme product that eases digestion), which generate respectively 15% and 12% of sales.

The head of research and consulting at Pharmexpert, Nikolai Bespalov puts the value of AVVA Rus' brand portfolio at $40 million-$50 million. Including the company's production facilities, deal could be worth $60 million-$80 million.

Pharmstandard announced earlier that it would spend $100 million on M&A deals this year. The company has already spent $60 million on a 50.1% stake in Bigpearl Trading Ltd, the beneficiary of I.I. Mechnikov Biomed, and about $20 million for 100% of drug maker Lekko. Pharmstandard financial director Yelena Arkhangelskaya said in October that the total amount of investment in acquisitions would not exceed $80 million before the end of this year.

Vp

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

February 19, 2019
 
05:05
Russia political and economic calendar: February 19
 
05:00
INTERFAX RUSSIA AND CIS BUSINESS AND FINANCIAL NEWS
 
February 18, 2019
 
22:07
New anti-Russian sanctions indicate EU's pro-U.S. policy - Duma's Slutsky (Part 2)
 
21:50
5 Ukrainian saboteurs hit landmine trying to infiltrate republic, Luhansk says
 
21:48
New anti-Russian sanctions indicate EU's pro-U.S. policy - Duma's Slutsky
 
21:43
Authorities considering adjustments to local history textbook criticized by Crimean Tatars
 
21:31
Michael Calvey, Philippe Delpal being held in good conditions - Public Monitoring Commission member Yenikeyev
 
21:28
Radicals protesting near Ukrainian Interior Ministry light firecrackers
 
21:23
EU'S SUPPORT FOR ANTI-RUSSIAN SANCTIONS FORCED BY U.S. INDICATES BRUSSELS' PRO-U.S. POLICY - DUMA'S SLUTSKY
 
21:21
Baring Vostok founder Calvey hopes for business ombudsman's aid for his release from custody - Public Monitoring Commission member
 
21:12
 
20:56
Warsaw conference yet another illustration of U.S. course towards creation of new dividing lines in Mideast - Russian Foreign Ministry (Part 2)
 
20:50
PUBLIC MONITORING COMMISSION: MICHAEL CALVEY, PHILIPPE DELPAL BEING HELD IN GOOD CONDITIONS AT "KREMLIN CENTRAL" JAIL, NOT COMPLAINING
 
20:49
MICHAEL CALVEY BELIEVES THAT INVESTIGATORS WILL BE ABLE TO ESTABLISH TRUTH, DETERMINE HIS INNOCENCE - PUBLIC MONITORING COMMISSION
 
 more headlines 



Interviews
 

.
Chairman of the German Committee on East European Economic Relations Wolfgang Büchele has given an interview to Interfax in which he speaks about the activity of German companies in Russia.

more
.
.
German Foreign Minister Heiko Maas has given an interview to Interfax ahead of his visit to Moscow in which he speaks about Germany‘s position on the INF Treaty and the Ukrainian settlement.

more
.
.
Russian lawyer Natalia Veselnitskaya has given an interview to Interfax in which she speaks about the charges brought against her in the United States.

more

 
  
 ©   1991—2019   "Interfax News Agency" JSC. All rights reserved.
Contact information   |   Privacy Policy   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100